Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs1544410
rs1544410
VDR
0.070 GeneticVariation BEFREE The TCTCTG-rs9533156-rs2073618-rs2073617-rs4950928-rs2228570-rs1544410 haplotype was significantly associated with increased BC </span>risk (adjusted odds ratio = 8.33; 95% confidence interval, 1.32-52.46; P = .025) compared with controls. 30309792

2019

dbSNP: rs1544410
rs1544410
VDR
0.070 GeneticVariation BEFREE Association of FokI (rs2228570) and BsmI (rs1544410) single nucleotide polymorphisms (SNPs) in VDR gene with the risk of breast cancer have been investigated in several studies, however, the published data are still inconsistent. 28780723

2018

dbSNP: rs1544410
rs1544410
VDR
0.070 GeneticVariation BEFREE Two common single nucleotide polymorphisms (SNPs) in the VDR gene, rs1544410 (BsmI) and rs2228570 (FokI), are inconsistently associated with breast cancer risk in Caucasian populations, while data for Asians are scarce. 26517870

2015

dbSNP: rs1544410
rs1544410
VDR
0.070 GeneticVariation BEFREE The role of the rs1544410 polymorphism of vitamin D receptor gene in breast cancer susceptibility. 25064221

2014

dbSNP: rs1544410
rs1544410
VDR
0.070 GeneticVariation BEFREE Sunlight measures were not associated with breast cancer risk, however significant interactions between time outdoors in the teen years and three unlinked genotypes were found for VDR (rs1544410, rs2228570) and CYP24A1 (rs1570669). 23393347

2013

dbSNP: rs1544410
rs1544410
VDR
0.070 GeneticVariation BEFREE The most extensively studied SNPs including rs10735810, also known as rs2228570 (Fok1, VDR), rs1544410 (Bsm1, VDR), and rs2296241 (CYP24A1), were not associated with breast cancer risk. 21828234

2011

dbSNP: rs1544410
rs1544410
VDR
0.070 GeneticVariation BEFREE No association was noted between rs1544410 (BsmI) BB and breast cancer risk overall (OR, 0.98; 95% CI, 0.89-1.09), but the BB genotype was associated with a significantly lower risk of advanced breast cancer (OR, 0.74; 95% CI, 0.60-0.92). 19124512

2009